US FDA Approved MediWound’s NexoBrid to Treat Serious Thermal Burns

MediWound Ltd. has announced that NexoBrid (anacaulase-bcdb), a treatment for adults with deep partial- or full-thickness thermal burns, has been approved by the U.S. Food and Drug Administration (FDA) for the removal of eschar. MediWound’s chief executive officer, Ofren Gonen, said that the FDA’s approval of NexoBrid, an innovative non-surgical treatment for severe burn injuries, […]

Continue Reading

US FDA Approves Roche’s COVID-19 Antibody Treatment

Roche reported that the U.S. Food and Drug Organization (FDA) has supported Actemra intravenous for the treatment of Coronavirus in hospitalized grown-up patients who are getting foundational corticosteroids and require supplemental oxygen, painless or obtrusive mechanical ventilation, or extracorporeal film oxygenation (ECMO). Actemra is the first monoclonal antibody for COVID-19 treatment that has been approved […]

Continue Reading